<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//acousort.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://acousort.com/mfn_news/</loc>
		<lastmod>2026-10-02T13:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-delarsrapport-for-perioden-juli-till-september-2024/</loc>
		<lastmod>2025-02-27T20:22:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-interim-report-for-the-period-july-september-2024/</loc>
		<lastmod>2025-02-27T20:22:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/us-cell-therapy-collaboration-enters-next-level-of-evaluation/</loc>
		<lastmod>2025-02-27T20:22:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/amerikanskt-cellterapisamarbete-gar-in-i-nasta-niva-av-utvardering/</loc>
		<lastmod>2025-02-27T20:22:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-to-meet-with-leading-cell-therapy-and-flow-cytometry-companies-at-two-upcoming-conferences/</loc>
		<lastmod>2025-02-27T20:22:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-traffar-ledande-foretag-inom-cellterapi-och-flodescytometri-vid-tva-kommande-konferenser/</loc>
		<lastmod>2025-02-27T20:22:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/year-end-report-for-acousort-ab-1-january-31-december-2024/</loc>
		<lastmod>2025-02-27T20:22:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/bokslutskommunike-for-acousort-ab-1-januari-31-december-2024/</loc>
		<lastmod>2025-02-27T20:22:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-tidigarelagger-bokslutskommunike-2024-till-14-februari-2025/</loc>
		<lastmod>2025-02-27T20:22:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-reschedules-the-2024-year-end-report-to-february-14-2025/</loc>
		<lastmod>2025-02-27T20:22:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-secures-working-capital-through-h1-2025/</loc>
		<lastmod>2025-02-27T20:22:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-sakrar-rorelsekapital-fram-till-halvarsskiftet-2025/</loc>
		<lastmod>2025-02-27T20:22:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-kommer-att-visa-upp-sin-unika-acoutrap-teknik-pa-tva-ev-konferenser/</loc>
		<lastmod>2025-02-27T20:22:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-selected-for-participation-in-global-bio-india-organized-by-the-indian-ministry-of-science-technology/</loc>
		<lastmod>2025-02-27T20:22:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-to-showcase-its-unique-acoutrap-technology-at-two-ev-conferences/</loc>
		<lastmod>2025-02-27T20:22:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/ledande-globalt-lakemedelsforetag-utvarderar-acouwash-for-kvalitetskontroll-i-fou-miljo/</loc>
		<lastmod>2025-02-27T20:22:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/leading-global-pharma-company-evaluates-acouwash-for-quality-control-in-an-rd-setting/</loc>
		<lastmod>2025-02-27T20:22:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/continued-efforts-expand-acousorts-presence-in-the-flow-cytometry-space/</loc>
		<lastmod>2025-02-27T20:22:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-fortsatter-sina-insatser-och-utokar-sin-narvaro-inom-flodescytometriomradet/</loc>
		<lastmod>2025-02-27T20:22:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-interim-report-for-the-period-april-june-2024/</loc>
		<lastmod>2025-02-27T20:22:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-deltar-i-isct-europe-for-att-expandera-sitt-natverk-inom-cellterapi/</loc>
		<lastmod>2025-02-27T20:22:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-to-attend-isct-europe-to-expand-its-network-in-the-cell-therapy-space/</loc>
		<lastmod>2025-02-27T20:22:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-inleder-samarbete-med-university-college-dublin/</loc>
		<lastmod>2025-02-27T20:22:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-enters-into-collaboration-with-university-college-dublin/</loc>
		<lastmod>2025-02-27T20:22:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-har-valts-ut-for-deltagande-i-global-bio-india-som-organiseras-av-det-indiska-ministeriet-for-vetenskap-och-teknik/</loc>
		<lastmod>2025-02-27T20:22:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-to-present-at-two-prestigious-conferences/</loc>
		<lastmod>2025-02-27T20:22:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-inleder-samarbete-med-usa-baserat-cellterapibolag/</loc>
		<lastmod>2025-02-27T20:22:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-enters-collaboration-with-us-based-cell-therapy-company/</loc>
		<lastmod>2025-02-27T20:22:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-enters-its-third-collaboration-within-flow-cytometry/</loc>
		<lastmod>2025-02-27T20:22:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-inleder-sitt-tredje-samarbete-inom-flodescytometri/</loc>
		<lastmod>2025-02-27T20:22:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/det-ledande-diagnostikforetaget-werfen-lanserar-banbrytande-poc-system-med-integrerad-akustofluidikteknologi/</loc>
		<lastmod>2025-02-27T20:22:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/the-leading-diagnostics-company-werfen-launches-groundbreaking-poc-system-with-integrated-acoustofluidic-technology/</loc>
		<lastmod>2025-02-27T20:22:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-delarsrapport-for-perioden-april-till-juni-2024/</loc>
		<lastmod>2025-02-27T20:22:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-utvalt-av-eic-for-deltagande-i-bio-for-tredje-gangen-och-inbjudet-for-att-visa-sina-losningar-i-iscts-innovation-zone/</loc>
		<lastmod>2025-02-27T20:22:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-selected-by-eic-for-participation-in-bio-for-the-third-time-and-also-invited-to-showcase-its-solutions-in-iscts-innovation-zone/</loc>
		<lastmod>2025-02-27T20:22:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-deltar-i-banbrytande-projekt-for-att-realisera-potentialen-i-forskning-om-extracellulara-vesiklar/</loc>
		<lastmod>2025-02-27T20:22:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-to-participate-in-a-pioneering-project-to-release-the-potential-in-extracellular-vesicles-research/</loc>
		<lastmod>2025-02-27T20:22:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/samarbetet-mellan-acousort-och-gensensor-utvecklas-enligt-plan/</loc>
		<lastmod>2025-02-27T20:22:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-and-gensensor-collaboration-develops-according-to-plan/</loc>
		<lastmod>2025-02-27T20:22:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-presenterar-pa-tva-prestigefyllda-konferenser/</loc>
		<lastmod>2025-02-27T20:22:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acouwash-placed-at-two-potential-oem-partners/</loc>
		<lastmod>2025-02-27T20:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acouwash-placeras-hos-tva-potentiella-oem-partners/</loc>
		<lastmod>2025-02-27T20:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-och-gensensor-inleder-samarbete-som-syftar-till-att-forbattra-bioreaktorodling/</loc>
		<lastmod>2025-02-27T20:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-and-gensensor-enter-collaboration-aiming-at-improving-bioreactor-culturing/</loc>
		<lastmod>2025-02-27T20:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/communique-from-the-annual-general-meeting-of-acousort-ab-publ/</loc>
		<lastmod>2025-02-27T20:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kommunike-fran-arsstamma-i-acousort-ab-publ/</loc>
		<lastmod>2025-02-27T20:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-staller-ut-pa-cyto-2024-for-att-demonstrera-fordelarna-med-akustisk-provberedning-for-applikationer-inom-flodescytometri/</loc>
		<lastmod>2025-02-27T20:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-will-exhibit-and-present-at-cyto-2024-demonstrating-the-benefits-of-acoustic-sample-preparation-for-flow-cytometry-applications/</loc>
		<lastmod>2025-02-27T20:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-interim-report-for-the-period-january-to-march-2024/</loc>
		<lastmod>2025-02-27T20:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-delarsrapport-for-perioden-januari-till-mars-2024/</loc>
		<lastmod>2025-02-27T20:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-annual-report-2023/</loc>
		<lastmod>2025-02-27T20:23:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-omstrukturerar-sin-nordamerikanska-forsaljningsverksamhet/</loc>
		<lastmod>2025-02-27T20:23:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-restructures-its-north-american-sales-operation/</loc>
		<lastmod>2025-02-27T20:23:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/vaxande-intresse-for-acoutrap-ev-isolering-for-nanoflodescytometri/</loc>
		<lastmod>2025-02-27T20:23:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/increased-interest-for-acoutrap-ev-isolation-for-nano-flow-cytometry-applications/</loc>
		<lastmod>2025-02-27T20:23:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/bokslutskommunike-for-acousort-ab-1-januari-31-december-2023/</loc>
		<lastmod>2025-02-27T20:23:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/year-end-report-for-acousort-ab-1-january-31-december-2023/</loc>
		<lastmod>2025-02-27T20:23:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/aktieagarintervju-med-acousorts-vd-torsten-freltoft-och-commercial-director-agnes-michanek/</loc>
		<lastmod>2025-02-27T20:23:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kallelse-till-arsstamma-i-acousort-ab-publ/</loc>
		<lastmod>2025-02-27T20:23:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/shareholder-interview-with-acousorts-ceo-torsten-freltoft-and-commercial-director-agnes-michanek/</loc>
		<lastmod>2025-02-27T20:23:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-arsredovisning-2023/</loc>
		<lastmod>2025-02-27T20:23:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-rights-issue-is-registered-conversion-of-btu-into-shares-and-warrants/</loc>
		<lastmod>2025-02-27T20:23:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-foretradesemissionen-ar-registrerad-omvandling-av-btu-till-aktier-och-teckningsoptioner/</loc>
		<lastmod>2025-02-27T20:23:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-attends-advanced-therapies-week-to-extend-its-cell-therapy-network/</loc>
		<lastmod>2025-02-27T20:23:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-styrelsen-beslutar-om-aterkop-av-teckningsoptioner-serie-2020-2023/</loc>
		<lastmod>2025-02-27T20:23:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-deltar-i-advanced-therapies-week-for-att-utoka-sitt-cellterapinatverk/</loc>
		<lastmod>2025-02-27T20:23:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/betydande-tekniska-framsteg-i-acousome-projektet-tva-nya-patentansokningar-inlamnade/</loc>
		<lastmod>2025-02-27T20:23:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-samarbetet-med-ett-ledande-cellterapibolag-expanderar-med-en-tredje-projektfas/</loc>
		<lastmod>2025-02-27T20:23:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-extends-collaboration-with-leading-cell-therapy-company-into-a-third-project-phase/</loc>
		<lastmod>2025-02-27T20:23:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/significant-technical-progress-in-the-acousome-project-two-novel-patent-applications-filed/</loc>
		<lastmod>2025-02-27T20:23:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-publishes-an-information-memorandum-in-connection-with-the-forthcoming-rights-issue-of-units/</loc>
		<lastmod>2025-02-27T20:23:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-offentliggor-informationsmemorandum-med-anledning-av-forestaende-foretradesemission-av-units/</loc>
		<lastmod>2025-02-27T20:23:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/last-day-of-trading-in-unit-rights-in-acousort/</loc>
		<lastmod>2025-02-27T20:23:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/sista-dag-for-handel-med-unitratter-i-acousort/</loc>
		<lastmod>2025-02-27T20:23:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-offentliggor-preliminart-utfall-i-foretradesemission/</loc>
		<lastmod>2025-02-27T20:23:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-announces-preliminary-outcome-of-rights-issue/</loc>
		<lastmod>2025-02-27T20:23:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-rights-issue-fully-subscribed/</loc>
		<lastmod>2025-02-27T20:23:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-foretradesemission-fulltecknad/</loc>
		<lastmod>2025-02-27T20:23:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/fda-godkannande-banar-vag-for-acousorts-forsta-oem-kommersialisering-inom-intensivvardsdiagnostik/</loc>
		<lastmod>2025-02-27T20:23:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/fda-approval-paves-the-way-for-acousorts-first-oem-commercialization-within-critical-care-diagnostics/</loc>
		<lastmod>2025-02-27T20:23:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/ceo-torsten-freltoft-presents-acousorts-opportunities-in-cell-therapy-and-diagnostics-at-lsx-nordic-congress-on-october-10/</loc>
		<lastmod>2025-02-27T20:23:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-levererar-fullt-fungerande-testsystem-for-automatiserad-cellhantering-inom-cellterapi/</loc>
		<lastmod>2025-02-27T20:23:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-presenterar-pa-biostock-life-science-summit-den-26-oktober/</loc>
		<lastmod>2025-02-27T20:23:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-delivers-fully-functional-test-system-for-automated-cell-handling-within-cell-therapy/</loc>
		<lastmod>2025-02-27T20:23:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-celltvatt-med-hog-kapacitet-for-cellterapi-en-viktig-milstolpe-mot-nya-oem-partnerskap/</loc>
		<lastmod>2025-02-27T20:23:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-high-throughput-cell-wash-for-cell-therapy-an-important-milestone-towards-new-oem-partnerships/</loc>
		<lastmod>2025-02-27T20:23:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-delarsrapport-for-perioden-juli-september-2023/</loc>
		<lastmod>2025-02-27T20:23:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-interim-report-for-the-period-july-september-2023/</loc>
		<lastmod>2025-02-27T20:23:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/styrelsen-for-acousort-beslutar-om-en-foretradesemission-av-units-om-cirka-248-msek/</loc>
		<lastmod>2025-02-27T20:23:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/the-board-of-directors-of-acousort-resolves-on-a-rights-issue-of-units-of-approximately-msek-24-8/</loc>
		<lastmod>2025-02-27T20:23:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-delivers-acoutrap-system-to-karolinska-institutet-as-partof-the-successful-indicell-project/</loc>
		<lastmod>2025-02-27T20:23:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-delarsrapport-for-perioden-april-juni-2023/</loc>
		<lastmod>2025-02-27T20:23:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-levererar-acoutrap-system-till-karolinska-institutet-som-en-del-av-det-framgangsrika-indicell-projektet/</loc>
		<lastmod>2025-02-27T20:23:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-to-participate-in-the-prestigious-nih-research-festival/</loc>
		<lastmod>2025-02-27T20:23:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kontinuerligt-vaxande-intresse-for-acousorts-forskningssystem/</loc>
		<lastmod>2025-02-27T20:23:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-deltar-i-prestigefyllda-nih-research-festival/</loc>
		<lastmod>2025-02-27T20:23:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/continuously-growing-interest-for-acousorts-research-systems/</loc>
		<lastmod>2025-02-27T20:23:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-to-present-its-unique-acoustofluidics-technology-at-the-international-conference-%c2%b5tas-2023/</loc>
		<lastmod>2025-02-27T20:23:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/vd-torsten-freltoft-presenterar-acousorts-potential-inom-cellterapi-och-diagnostik-pa-lsx-nordic-congress-den-10-oktober/</loc>
		<lastmod>2025-02-27T20:23:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-presenterar-sin-unika-teknologi-for-akusto-fluidik-den-internationella-konferensen-%ce%bctas-2023/</loc>
		<lastmod>2025-02-27T20:23:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-starker-sin-fou-kapacitet-genom-rekrytering-av-henrik-johansson/</loc>
		<lastmod>2025-02-27T20:23:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-strengthens-its-rd-capabilities-by-the-recruitment-of-henrik-johansson/</loc>
		<lastmod>2025-02-27T20:23:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/cell-therapy-collaboration-with-leading-global-life-science-company-continues-to-expand/</loc>
		<lastmod>2025-02-27T20:23:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/cellterapisamarbetet-med-ett-ledande-globalt-life-science-foretag-fortsatter-att-expandera/</loc>
		<lastmod>2025-02-27T20:23:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-inbjudet-att-forelasa-pa-acoustofluidics-konferens/</loc>
		<lastmod>2025-02-27T20:23:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-invited-to-give-a-lecture-at-the-acoustofluidics-conference/</loc>
		<lastmod>2025-02-27T20:23:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-interim-report-for-the-period-april-june-2023/</loc>
		<lastmod>2025-02-27T20:23:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-expands-its-reach-to-flow-cytometry/</loc>
		<lastmod>2025-02-27T20:23:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-lanserar-nasta-generations-acoutrap-pa-cyto-2023/</loc>
		<lastmod>2025-02-27T20:23:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-launches-next-generation-acoutrap-at-cyto-2023/</loc>
		<lastmod>2025-02-27T20:23:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-interim-report-for-the-period-january-march-2023/</loc>
		<lastmod>2025-02-27T20:23:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-delarsrapport-for-perioden-januari-mars-2023/</loc>
		<lastmod>2025-02-27T20:23:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-fortsatter-sitt-strategiska-samarbete-med-akademin-levererar-unikt-acouwash-2-system-till-lunds-universitet/</loc>
		<lastmod>2025-02-27T20:23:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-continues-its-strategic-collaboration-with-academia-delivers-a-unique-acouwash-2-system-to-lund-university/</loc>
		<lastmod>2025-02-27T20:23:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/komplettering-av-kallelse-till-arsstamma-i-acousort-ab-publ/</loc>
		<lastmod>2025-02-27T20:23:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/czech-research-group-sees-novel-opportunities-for-acouwash-in-fish-sperm-refinement/</loc>
		<lastmod>2025-02-27T20:23:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/tjeckisk-forskargrupp-ser-helt-nya-mojligheter-for-acouwash-vid-forfining-av-fiskspermier/</loc>
		<lastmod>2025-02-27T20:23:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-selected-by-eic-for-participation-in-leading-medical-exhibition-for-the-third-time/</loc>
		<lastmod>2025-02-27T20:23:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kommunike-fran-arsstamma-i-acousort-ab-publ-2/</loc>
		<lastmod>2025-02-27T20:23:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/the-prestigious-us-national-institute-of-health-becomes-a-returning-customer-to-acousort/</loc>
		<lastmod>2025-02-27T20:23:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-expanderar-till-flodescytometri/</loc>
		<lastmod>2025-02-27T20:23:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/utokat-cellterapisamarbete-genererar-intakter-pa-130-000-euro-under-2023/</loc>
		<lastmod>2025-02-27T20:23:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/japanskt-samarbetsavtal-forlangs-for-att-mojliggora-slutlig-utvardering-med-kliniska-prover/</loc>
		<lastmod>2025-02-27T20:23:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/japanese-collaboration-agreement-extended-to-allow-final-evaluation-of-performance-on-clinical-samples/</loc>
		<lastmod>2025-02-27T20:23:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-bokslutskommunike-for-rakenskapsaret-2022/</loc>
		<lastmod>2025-02-27T20:23:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/strategiuppdatering/</loc>
		<lastmod>2025-02-27T20:23:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kallelse-till-arsstamma-i-acousort-ab-publ-2/</loc>
		<lastmod>2025-02-27T20:23:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-arsredovisning-2022/</loc>
		<lastmod>2025-02-27T20:23:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/the-stem-cell-therapy-project-blue4therapy-brought-to-a-highly-successful-close/</loc>
		<lastmod>2025-02-27T20:23:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/stamcellsterapiprojektet-blue4therapy-har-slutforts-pa-ett-mycket-framgangsrikt-satt/</loc>
		<lastmod>2025-02-27T20:23:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-delarsrapport-for-perioden-januari-september-2022/</loc>
		<lastmod>2025-02-27T20:23:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-presents-at-stora-aktiedagen-in-stockholm-november-30-addressing-current-developments-in-the-vibrant-cell-therapy-space/</loc>
		<lastmod>2025-02-27T20:23:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-presenterar-pa-stora-aktiedagen-i-stockholm-den-30-november-for-att-tala-om-utvecklingen-inom-det-intensiva-cellterapiomradet/</loc>
		<lastmod>2025-02-27T20:23:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/biowings-projektet-skapar-nya-mojligheter-for-storskalig-produktion-och-exosombaserad-diagnostik/</loc>
		<lastmod>2025-02-27T20:23:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/the-biowings-project-creates-new-opportunities-for-large-scale-production-and-exosome-based-diagnostics/</loc>
		<lastmod>2025-02-27T20:23:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/two-of-acousorts-board-members-and-ceo-acquire-shares/</loc>
		<lastmod>2025-02-27T20:23:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/tva-av-acousorts-styrelsemedlemmar-och-vd-forvarvar-aktier/</loc>
		<lastmod>2025-02-27T20:23:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-och-bluecell-i-kommersiell-planering-i-takt-med-att-stamcellsterapiprojektet-blue4therapy-narmar-sig-slutforande/</loc>
		<lastmod>2025-02-27T20:23:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-and-bluecell-in-commercial-planning-as-the-stem-cell-therapy-project-blue4therapy-approaches-completion/</loc>
		<lastmod>2025-02-27T20:23:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/extended-collaboration-targeting-cell-therapies-generates-revenues-of-eur-130000-in-2023/</loc>
		<lastmod>2025-02-27T20:23:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-to-supply-lund-university-with-unique-pre-focusing-technology-to-enable-high-precision-cell-separation/</loc>
		<lastmod>2025-02-27T20:23:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/visit-aktiedagen-lund-september-26-and-learn-how-ultrasound-can-be-used-to-fight-the-worlds-deadliest-diseases/</loc>
		<lastmod>2025-02-27T20:23:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-roll-i-blue4therapy-projektet-expanderar-700-000-sek-i-ytterligare-intakter-under-2022/</loc>
		<lastmod>2025-02-27T20:23:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-role-in-the-blue4therapy-project-expands-sek-700000-in-additional-revenue-in-2022/</loc>
		<lastmod>2025-02-27T20:23:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-reser-till-japan-for-att-ateruppta-marknadsforingsarbetet-nar-landet-nu-oppnar-upp-efter-pandemin/</loc>
		<lastmod>2025-02-27T20:23:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-travels-to-japan-to-re-ignite-marketing-efforts-as-the-country-opens-up-after-the-pandemic/</loc>
		<lastmod>2025-02-27T20:23:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-forser-lunds-universitet-med-unik-forfokuseringsteknik-for-att-mojliggora-cellseparation-med-hog-precision/</loc>
		<lastmod>2025-02-27T20:23:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-expands-its-cell-therapy-efforts-and-enters-collaboration-with-global-life-science-company/</loc>
		<lastmod>2025-02-27T20:23:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-expanderar-sin-verksamhet-inom-cellterapi-och-etablerar-samarbete-med-globalt-life-science-bolag/</loc>
		<lastmod>2025-02-27T20:23:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kom-till-aktiedagen-lund-26-september-for-att-fa-veta-mer-om-hur-ultraljud-kan-anvandas-for-att-bekampa-varldens-dodligaste-sjukdomar/</loc>
		<lastmod>2025-02-27T20:23:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-utvalt-av-eic-for-deltagande-pa-medica-europas-ledande-medicinska-utstallning/</loc>
		<lastmod>2025-02-27T20:23:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-selected-by-eic-for-participation-at-medica-europes-leading-medical-exhibition/</loc>
		<lastmod>2025-02-27T20:23:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-delarsrapport-for-perioden-januari-juni-2022/</loc>
		<lastmod>2025-02-27T20:23:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/european-innovation-council-eic-tilldelar-acousort-projektet-acousome-26-miljoner-kronor-for-att-utveckla-banbrytande-teknik-for-exosombaserad-diagnostik/</loc>
		<lastmod>2025-02-27T20:23:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/the-european-innovation-council-eic-awards-the-acousort-project-acousome-sek-26-million-to-develop-groundbreaking-technology-for-exosome-based-diagnostics/</loc>
		<lastmod>2025-02-27T20:23:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-starker-sin-kommersiella-kapacitet-pa-ett-betydande-satt-genom-rekryteringarna-av-kelley-intehar-och-agnes-michanek/</loc>
		<lastmod>2025-02-27T20:23:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-significantly-strengthens-its-commercial-capabilities-with-the-recruitments-of-kelley-intehar-and-agnes-michanek/</loc>
		<lastmod>2025-02-27T20:23:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-and-werfens-joint-patent-application-has-received-national-approval-in-the-us/</loc>
		<lastmod>2025-02-27T20:23:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-och-werfens-gemensamma-patentansokan-har-erhallit-nationellt-godkannande-i-usa/</loc>
		<lastmod>2025-02-27T20:23:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-vetenskapliga-framsteg-med-acouwash-mojliggor-ny-metod-for-overvakning-av-cancerbehandling/</loc>
		<lastmod>2025-02-27T20:23:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-scientific-progress-with-acouwash-enables-new-method-for-cancer-treatment-monitoring/</loc>
		<lastmod>2025-02-27T20:23:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-interim-report-2022-01-01-2022-03-31/</loc>
		<lastmod>2025-02-27T20:23:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-delarsrapport-2022-01-01-2022-03-31/</loc>
		<lastmod>2025-02-27T20:23:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-sells-acouwash-system-to-pharmacolog/</loc>
		<lastmod>2025-02-27T20:23:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-saljer-ett-acouwash-system-till-pharmacolog/</loc>
		<lastmod>2025-02-27T20:23:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-utvalt-av-eic-for-deltagande-pa-ledande-medicinsk-konferens/</loc>
		<lastmod>2025-02-27T20:23:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-selected-by-eic-for-participation-in-leading-medical-exhibition/</loc>
		<lastmod>2025-02-27T20:23:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-places-a-modified-acouwash-at-lund-university-to-support-cancer-research/</loc>
		<lastmod>2025-02-27T20:23:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-placerar-en-modifierad-acouwash-vid-lunds-universitet-for-att-stodja-cancerforskning/</loc>
		<lastmod>2025-02-27T20:23:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kommunike-fran-arsstamma-i-acousort-ab-publ-3/</loc>
		<lastmod>2025-02-27T20:23:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-arsredovisning-2021/</loc>
		<lastmod>2025-02-27T20:23:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-arsredovisning-for-2021/</loc>
		<lastmod>2025-02-27T20:23:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kallelse-till-arsstamma-i-acousort-ab-publ-3/</loc>
		<lastmod>2025-02-27T20:23:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-expands-and-moves-to-new-larger-premises/</loc>
		<lastmod>2025-02-27T20:23:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-vaxer-och-flyttar-till-nya-storre-lokaler/</loc>
		<lastmod>2025-02-27T20:23:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-interim-report-2021-10-01-2021-12-31/</loc>
		<lastmod>2025-02-27T20:23:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-delarsrapport-2021-10-01-2021-12-31/</loc>
		<lastmod>2025-02-27T20:23:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-receives-notice-of-allowance-in-the-us-for-patent-on-plastic-chips/</loc>
		<lastmod>2025-02-27T20:23:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-far-notice-of-allowance-i-usa-for-patent-pa-chip-tillverkade-i-plast/</loc>
		<lastmod>2025-02-27T20:23:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-extends-collaboration-agreement-with-japanese-life-science-partner/</loc>
		<lastmod>2025-02-27T20:23:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-forlanger-samarbetsavtal-med-japansk-life-science-partner/</loc>
		<lastmod>2025-02-27T20:23:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kommunike-fran-extra-bolagsstamma-i-acousort-ab-publ/</loc>
		<lastmod>2025-02-27T20:23:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kallelse-till-extra-bolagsstamma-i-acousort-ab-publ/</loc>
		<lastmod>2025-02-27T20:23:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/interim-report-2021-07-01-2021-09-31/</loc>
		<lastmod>2025-02-27T20:23:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/delarsrapport-2021-07-01-2021-09-30/</loc>
		<lastmod>2025-02-27T20:23:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-takes-next-step-in-commercial-collaboration-with-californian-life-science-company/</loc>
		<lastmod>2025-02-27T20:23:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-saljer-ytterligare-en-acoutrap-till-sydkoreansk-kund/</loc>
		<lastmod>2025-02-27T20:23:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-tar-nasta-steg-i-kommersiellt-samarbete-med-kaliforniskt-life-science-foretag/</loc>
		<lastmod>2025-02-27T20:23:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-launches-its-first-oem-product-acouplasmaoptical/</loc>
		<lastmod>2025-02-27T20:23:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-lanserar-sin-forsta-oem-produkt-acouplasmaoptical/</loc>
		<lastmod>2025-02-27T20:23:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/emissionen-registrerad-och-handeln-med-btu-upphor/</loc>
		<lastmod>2025-02-27T20:23:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-sells-additional-acoutrap-to-south-korean-customer/</loc>
		<lastmod>2025-02-27T20:23:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-tillfors-396-msek-i-genomford-foretradesemission/</loc>
		<lastmod>2025-02-27T20:23:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/martin-linde-leaves-the-board-of-acousort-for-health-reasons/</loc>
		<lastmod>2025-02-27T20:23:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/martin-linde-lamnar-styrelsen-i-acousort-av-halsoskal/</loc>
		<lastmod>2025-02-27T20:23:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-startar-nytt-projekt-med-instrumentation-laboratory/</loc>
		<lastmod>2025-02-27T20:23:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-far-125-miljoner-kronor-i-vinnova-finansiering-for-utveckling-av-individualiserade-stamcellsbehandlingar/</loc>
		<lastmod>2025-02-27T20:23:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-offentliggor-prospekt/</loc>
		<lastmod>2025-02-27T20:23:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-launches-acouwash-2-today/</loc>
		<lastmod>2025-02-27T20:23:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-launches-new-project-with-instrumentation-laboratory/</loc>
		<lastmod>2025-02-27T20:23:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-far-125-miljoner-kronor-i-vinnova-finansiering-for-utveckling-av-individualiserade-stamcellsbehandlingar/</loc>
		<lastmod>2025-02-27T20:23:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-receives-1-25-million-sek-in-vinnova-funding-for-the-development-of-individualized-stem-cell-treatments/</loc>
		<lastmod>2025-02-27T20:23:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-will-launch-acouwash-2-at-international-conference/</loc>
		<lastmod>2025-02-27T20:23:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-lanserar-acouwash-2-pa-internationell-konferens/</loc>
		<lastmod>2025-02-27T20:23:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-genomfor-fullt-sakerstalld-foretradesemission-av-units-om-cirka-40-msek/</loc>
		<lastmod>2025-02-27T20:23:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-interim-report-2021-04-01-2021-06-30/</loc>
		<lastmod>2025-02-27T20:23:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-delarsrapport-2021-04-01-2021-06-30/</loc>
		<lastmod>2025-02-27T20:23:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/martin-olin-becomes-ceo-of-norwegian-bergenbio-continues-as-chairman-for-acousort/</loc>
		<lastmod>2025-02-27T20:23:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/martin-olin-utsedd-till-vd-for-norska-bergenbio-blir-kvar-som-ordforande-i-acousort/</loc>
		<lastmod>2025-02-27T20:23:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-saljer-acouwash-system-till-japansk-distributor/</loc>
		<lastmod>2025-02-27T20:23:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-sells-acouwash-system-to-japanese-distributor/</loc>
		<lastmod>2025-02-27T20:23:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/first-collaboration-phase-with-belgian-diagnostics-company-finalized/</loc>
		<lastmod>2025-02-27T20:23:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/forsta-samarbetsfasen-med-belgiskt-diagnostikforetag-genomford/</loc>
		<lastmod>2025-02-27T20:23:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-reaches-milestone-for-acouplasma-optical/</loc>
		<lastmod>2025-02-27T20:23:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-nar-milstolpe-for-acouplasma-optical/</loc>
		<lastmod>2025-02-27T20:23:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/korrigering-acousort-delarsrapport-2021-01-01-2021-03-31/</loc>
		<lastmod>2025-02-27T20:23:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/cerrection-acousort-interim-report-2021-01-01-2021-03-31/</loc>
		<lastmod>2025-02-27T20:23:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-delarsrapport-2021-01-01-2021-03-31/</loc>
		<lastmod>2025-02-27T20:23:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-interim-report-2021-01-01-2021-03-31/</loc>
		<lastmod>2025-02-27T20:23:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/promising-results-in-acousorts-latest-feasibility-study-with-instrumentation-laboratory/</loc>
		<lastmod>2025-02-27T20:23:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/lovande-resultat-i-acousorts-senaste-forstudie-med-instrumentation-laboratory/</loc>
		<lastmod>2025-02-27T20:23:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-och-pharmacolog-undertecknar-avsiktsforklaring-for-att-undersoka-integration-av-acousorts-blodseparationsteknik/</loc>
		<lastmod>2025-02-27T20:23:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-and-pharmacolog-sign-letter-of-intent-to-investigate-integration-of-acousorts-blood-separation-technology/</loc>
		<lastmod>2025-02-27T20:23:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/martin-olin-appointed-new-chairman-of-the-board-in-acousort/</loc>
		<lastmod>2025-02-27T20:23:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/martin-olin-utsedd-till-ny-styrelseordforande-i-acousort/</loc>
		<lastmod>2025-02-27T20:23:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kommunike-fran-arsstamma-i-acousort-ab-publ-4/</loc>
		<lastmod>2025-02-27T20:23:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-annual-report-2020/</loc>
		<lastmod>2025-02-27T20:23:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/styrelseledamot-kristian-enkvist-avgar-pa-egen-begaran/</loc>
		<lastmod>2025-02-27T20:23:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kallelse-till-arsstamma-i-acousort-ab-publ-4/</loc>
		<lastmod>2025-02-27T20:23:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-starker-sitt-kommersiella-erbjudande-med-nya-acouwash-applikationer/</loc>
		<lastmod>2025-02-27T20:23:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-strengthens-commercial-offering-with-the-release-of-new-acouwash-application-notes/</loc>
		<lastmod>2025-02-27T20:23:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/correction-regarding-the-date-of-the-ordinary-general-assembly/</loc>
		<lastmod>2025-02-27T20:23:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-year-end-report-2020-01-01-2020-12-31/</loc>
		<lastmod>2025-02-27T20:23:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-invites-to-a-live-broadcasted-press-conference-due-to-publication-of-year-end-report/</loc>
		<lastmod>2025-02-27T20:23:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-bokslutskommunike-2020-01-01-2020-12-31/</loc>
		<lastmod>2025-02-27T20:23:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-haller-livesand-presstraff-med-anledning-av-publicering-av-bokslutskommunike/</loc>
		<lastmod>2025-02-27T20:23:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-sakrar-teknikrattigheter-fran-dtu/</loc>
		<lastmod>2025-02-27T20:23:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-secures-technology-rights-from-dtu/</loc>
		<lastmod>2025-02-27T20:23:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ingar-samarbetsavtal-med-belgiskt-diagnostikbolag/</loc>
		<lastmod>2025-02-27T20:23:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-enters-collaboration-agreement-with-a-belgian-diagnostics-company/</loc>
		<lastmod>2025-02-27T20:23:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-utses-till-basta-ir-vardeskapare-inom-healthcare-i-norden-2020/</loc>
		<lastmod>2025-02-27T20:23:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-awarded-best-healthcare-ir-value-creation-nordics-2020/</loc>
		<lastmod>2025-02-27T20:23:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-starker-organisationen-med-business-development-manager/</loc>
		<lastmod>2025-02-27T20:23:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-strengthens-organization-with-business-development-manager/</loc>
		<lastmod>2025-02-27T20:23:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-sells-acoutrap-system-to-japanese-distributor/</loc>
		<lastmod>2025-02-27T20:23:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-saljer-acoutrap-system-till-japansk-distributor/</loc>
		<lastmod>2025-02-27T20:23:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acoutrap-system-salt-till-koreansk-life-science-partner/</loc>
		<lastmod>2025-02-27T20:23:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/fornyat-samarbetsavtal-signerat-med-japansk-life-science-partner/</loc>
		<lastmod>2025-02-27T20:23:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/idag-inleds-handeln-av-acousorts-aktie-pa-nasdaq-first-north-growth-market/</loc>
		<lastmod>2025-02-27T20:23:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-incitamentsprogram-optionsprogram-serie-2020-2023-har-registrerats-hos-bolagsverket/</loc>
		<lastmod>2025-02-27T20:23:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-godkanda-for-notering-pa-nasdaq-first-north-growth-market/</loc>
		<lastmod>2025-02-27T20:23:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-delarsrapport-q3-2020-07-01-2020-09-30/</loc>
		<lastmod>2025-02-27T20:23:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-far-tva-patentansokningar-publicerade/</loc>
		<lastmod>2025-02-27T20:23:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ansoker-om-listning-pa-nasdaq-first-north-growth-market/</loc>
		<lastmod>2025-02-27T20:23:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-far-order-pa-acoutrap-fran-university-of-kentucky/</loc>
		<lastmod>2025-02-27T20:23:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-inleder-nytt-projekt-med-instrumentation-laboratory/</loc>
		<lastmod>2025-02-27T20:23:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-deltar-pa-investerarjakten/</loc>
		<lastmod>2025-02-27T20:23:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-inleder-arbetet-i-projektet-blue4therapy-forsta-steget-mot-framtidens-stamcellsbehandling/</loc>
		<lastmod>2025-02-27T20:23:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-deltar-i-ett-nytt-viktigt-camp-projekt/</loc>
		<lastmod>2025-02-27T20:23:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/delarsrapport-q2-2020-04-01-2020-06-30/</loc>
		<lastmod>2025-02-27T20:23:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-sluter-avtal-med-koreanskt-life-science-foretag/</loc>
		<lastmod>2025-02-27T20:23:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-har-framgangsrikt-slutfort-produktutvecklingsuppdrag-at-intrumentation-laboratory/</loc>
		<lastmod>2025-02-27T20:23:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/analyst-group-publicerar-aktieanalys-av-acousort/</loc>
		<lastmod>2025-02-27T20:23:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-genomfor-en-riktad-emission-om-117-msek-for-att-slutfora-utveckling-av-foretagets-forsta-serietill-verkade-oem-moduler-samt-produktionslinjen-for-dessa/</loc>
		<lastmod>2025-02-27T20:23:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-erhaller-iso-13485-certifiering-viktigt-steg-i-kommersialiseringen/</loc>
		<lastmod>2025-02-27T20:23:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-erhaller-300-000-euro-i-eurostars-anslag-for-att-utveckla-utrustning-for-stamcellsterapi/</loc>
		<lastmod>2025-02-27T20:23:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kommunike-fran-arsstamma-i-acousort-ab-publ-5/</loc>
		<lastmod>2025-02-27T20:23:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-sluter-avtal-med-university-of-kentucky-for-utvardering-av-acoutrap/</loc>
		<lastmod>2025-02-27T20:23:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/delarsrapport-q1-2020-01-01-2020-03-31/</loc>
		<lastmod>2025-02-27T20:23:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-annual-report-2019/</loc>
		<lastmod>2025-02-27T20:23:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-far-toppbetyg-fran-eurostars-for-projekt-kring-stamcellsbehandling/</loc>
		<lastmod>2025-02-27T20:23:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-presenterar-uppdaterad-strategi-2020-2030/</loc>
		<lastmod>2025-02-27T20:23:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-sakerstaller-rorelsekapital-for-2020/</loc>
		<lastmod>2025-02-27T20:23:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kallelse-till-arsstamma-i-acousort-ab-publ-5/</loc>
		<lastmod>2025-02-27T20:23:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/analyst-group-inleder-analysbevakning-av-acousort/</loc>
		<lastmod>2025-02-27T20:23:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-leverans-av-acouwash-till-umea-universitet/</loc>
		<lastmod>2025-02-27T20:23:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-beviljas-patent-for-ny-metod-att-separera-celler-med-ljud/</loc>
		<lastmod>2025-02-27T20:23:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ger-lagesrapport-stort-intresse-for-bolagets-teknik-trots-installda-konferenser/</loc>
		<lastmod>2025-02-27T20:23:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/korrigering-bokslutskommunike-2019/</loc>
		<lastmod>2025-02-27T20:23:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-utfor-utvarderingsuppdrag-at-globalt-life-science-foretag/</loc>
		<lastmod>2025-02-27T20:23:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-far-order-fran-instrumentation-laboratory-vard-42-000-usd/</loc>
		<lastmod>2025-02-27T20:23:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-far-order-pa-acoutrap-fran-region-orebro-lan/</loc>
		<lastmod>2025-02-27T20:23:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-far-order-pa-uppgraderad-acouwash-fran-umea-universitet/</loc>
		<lastmod>2025-02-27T20:23:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-signerar-samarbetsavtal-med-multinationellt-life-science-foretag/</loc>
		<lastmod>2025-02-27T20:23:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-sluter-tva-avtal-med-stor-japansk-industriell-aktor/</loc>
		<lastmod>2025-02-27T20:23:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-grundare-thomas-laurell-far-48-miljoner-kronor-i-forskningsanslag-kvalitetsstampel-for-acousorts-teknik/</loc>
		<lastmod>2025-02-27T20:23:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-far-ce-markning-for-acouwash-oppnar-for-oem-samarbeten-och-kommersialisering/</loc>
		<lastmod>2025-02-27T20:23:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-lanserar-nytt-product-sheet-pa-genomics-live/</loc>
		<lastmod>2025-02-27T20:23:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/delarsrapport-q3-2019-07-01-2019-09-30/</loc>
		<lastmod>2025-02-27T20:23:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-installerar-acouwash-hos-stor-industriell-aktor-i-japan/</loc>
		<lastmod>2025-02-27T20:23:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/produktutvecklingsuppdrag-framgangsrikt-slutfort-at-instrumentation-laboratory/</loc>
		<lastmod>2025-02-27T20:23:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-far-order-pa-acoutrap-fran-sydkorea/</loc>
		<lastmod>2025-02-27T20:23:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-tecknar-exklusivt-avtal-med-japansk-distributor/</loc>
		<lastmod>2025-02-27T20:23:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-deltar-och-presenterar-pa-microtas-i-schweiziska-basel/</loc>
		<lastmod>2025-02-27T20:23:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-inleder-projektet-acouplast-ska-ta-fram-kostnadseffektiva-chip-for-separation-av-blodplasma/</loc>
		<lastmod>2025-02-27T20:23:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/per-augustsson-far-startbidrag-fran-europeiska-forskningsradet-for-forskning-inom-akustofluidik/</loc>
		<lastmod>2025-02-27T20:23:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/delarsrapport-q2-2019-04-01-2019-06-30/</loc>
		<lastmod>2025-02-27T20:23:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-implementerar-sin-teknik-i-kliniskt-analyssystem/</loc>
		<lastmod>2025-02-27T20:23:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-erhaller-400-000-euro-i-eurostars-anslag-for-att-separera-blodplasma-med-ultraljud-i-polymerchip/</loc>
		<lastmod>2025-02-27T20:23:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-publicerar-ytterligare-demonstrationsmaterial-for-deltagandet-pa-cyto-2019-i-vancouver-kanada/</loc>
		<lastmod>2025-02-27T20:23:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/vetenskapliga-framsteg-med-hjalp-av-acoutrap-potentiell-biomarkor-for-kranskarlssjukdomar-hittad/</loc>
		<lastmod>2025-02-27T20:23:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/vetenskapliga-framsteg-med-hjalp-av-acoutrap-potentiell-biomarkor-for-kranskarlssjukdomar-hittad-2/</loc>
		<lastmod>2025-02-27T20:23:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-inleder-samarbete-med-medicinskt-center-vid-amsterdams-universitet/</loc>
		<lastmod>2025-02-27T20:23:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kommunike-fran-arsstamma-i-acousort-ab-publ-6/</loc>
		<lastmod>2025-02-27T20:23:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-projekt-for-att-separera-blodplasma-med-ultraljud-i-polymerchip-far-toppbetyg-infor-utdelning-av-eu-anslag/</loc>
		<lastmod>2025-02-27T20:23:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-publicerar-arsredovisning-for-2018/</loc>
		<lastmod>2025-02-27T20:23:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/delarsrapport-q1-2019-01-01-2019-03-31/</loc>
		<lastmod>2025-02-27T20:23:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kallelse-till-arsstamma-i-acousort-ab-publ-6/</loc>
		<lastmod>2025-02-27T20:23:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-presenterar-pa-smabolagsjakten-live-den-28-maj/</loc>
		<lastmod>2025-02-27T20:23:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acoutrap-system-installeras-pa-ett-av-europas-storsta-lakemedelsforetag/</loc>
		<lastmod>2025-02-27T20:23:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-publicerar-ytterligare-demonstrationsmaterial-infor-deltagandet-pa-isev-2019-i-japan/</loc>
		<lastmod>2025-02-27T20:23:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/qa-med-vd-torsten-freltoft/</loc>
		<lastmod>2025-02-27T20:23:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-partner-i-mangmiljonsatsning-pa-cell-och-genterapi/</loc>
		<lastmod>2025-02-27T20:23:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/stort-intresse-for-acousort-pa-konferens-inom-molekylar-medicin/</loc>
		<lastmod>2025-02-27T20:23:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/nytt-demonstrationsmaterial-visar-fordelarna-med-acoutrap/</loc>
		<lastmod>2025-02-27T20:23:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-internationella-patentansokan-for-polymerbaserade-komponenter-har-publicerats/</loc>
		<lastmod>2025-02-27T20:23:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/bokslutskommunike-2018/</loc>
		<lastmod>2025-02-27T20:23:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/okat-fokus-pa-kommersialisering-under-2019/</loc>
		<lastmod>2025-02-27T20:23:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acouwash-nomineras-av-the-scientist-som-en-av-2018-ars-basta-innovationer/</loc>
		<lastmod>2025-02-27T20:23:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/delarsrapport-2018-01-01-till-2018-09-30/</loc>
		<lastmod>2025-02-27T20:23:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-erhaller-bidrag-fran-eus-horizon-2020-program/</loc>
		<lastmod>2025-02-27T20:23:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/viktiga-framsteg-i-acousort/</loc>
		<lastmod>2025-02-27T20:23:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-starker-sin-kommersiella-profil/</loc>
		<lastmod>2025-02-27T20:23:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/delarsrapport-2018-01-01-till-2018-06-30/</loc>
		<lastmod>2025-02-27T20:23:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/fortydligande-kring-avtalet-med-instrumentation-laboratory/</loc>
		<lastmod>2025-02-27T20:23:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-lamnar-nulagesrapport/</loc>
		<lastmod>2025-02-27T20:23:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kommunike-fran-arsstamma-i-acousort-ab-publ-7/</loc>
		<lastmod>2025-02-27T20:23:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-uppnar-viktig-milstolpe-och-tecknar-licens-och-distributionsavtal-med-instrumentation-laboratory/</loc>
		<lastmod>2025-02-27T20:23:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/flaggning-i-acousort-ab/</loc>
		<lastmod>2025-02-27T20:23:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/arsredovisning-2017/</loc>
		<lastmod>2025-02-27T20:23:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/marknadsmeddelande-122-18-sista-dag-for-handel-med-bta-i-acousort-ab/</loc>
		<lastmod>2025-02-27T20:23:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/sista-dag-for-handel-med-bta-21-maj-2018/</loc>
		<lastmod>2025-02-27T20:23:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-delarsrapport-2018-01-01-till-2018-03-31/</loc>
		<lastmod>2025-02-27T20:23:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kallelse-till-arsstamma-i-acousort-ab-publ-7/</loc>
		<lastmod>2025-02-27T20:23:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/foretradesemission-tecknad-till-125-procent-motsvarande-281-msek/</loc>
		<lastmod>2025-02-27T20:23:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-gemensam-patentansokan-med-amerikanska-instrumentation-laboratory/</loc>
		<lastmod>2025-02-27T20:23:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-erhaller-eu-bidrag-pa-sek-1-8-millioner/</loc>
		<lastmod>2025-02-27T20:23:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/idag-inleds-teckningstiden-i-acousort-abs-foretradesemission-om-cirka-225-msek/</loc>
		<lastmod>2025-02-27T20:23:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-offentliggor-memorandum-teaser-och-anmalningssedel/</loc>
		<lastmod>2025-02-27T20:23:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/uppdatering-avseende-kommersialiseringsavtal-med-oem-partner-1/</loc>
		<lastmod>2025-02-27T20:23:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kommunike-fran-extra-bolagsstamma-i-acousort-den-21-mars-2018/</loc>
		<lastmod>2025-02-27T20:23:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/marknadsmeddelande-60-18-information-om-foretradesemission-i-acousort-ab/</loc>
		<lastmod>2025-02-27T20:23:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kallelse-till-extra-bolagsstamma-i-acousort-ab/</loc>
		<lastmod>2025-02-27T20:23:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-beslutar-om-foretradesemission-om-cirka-225-msek-med-teckningsforbindelser-om-circa-54-villkorat-av-godkannande-vid-extra-bolagsstamma/</loc>
		<lastmod>2025-02-27T20:23:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/bokslutskommunike-2017/</loc>
		<lastmod>2025-02-27T20:23:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-erhaller-ce-markning-for-acoutrap/</loc>
		<lastmod>2025-02-27T20:23:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-lamnar-nulagesrapport-efter-ett-ar-som-noterat-bolag/</loc>
		<lastmod>2025-02-27T20:23:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-forvarvar-uppfinning-med-patentratt-fran-dtu/</loc>
		<lastmod>2025-02-27T20:23:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-publ-avtalar-om-term-sheet-for-kommande-kommersialiseringsavtal/</loc>
		<lastmod>2025-02-27T20:23:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-delarsrapport-2017-01-01-till-2017-09-30/</loc>
		<lastmod>2025-02-27T20:23:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-publ-tecknar-nytt-avtal-med-life-science-partner-3/</loc>
		<lastmod>2025-02-27T20:23:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-uppdaterar-kring-utvecklingen-i-bolagets-oem-projekt-och-forskningssystem/</loc>
		<lastmod>2025-02-27T20:23:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ingar-agentavtal-med-dr-sean-higgins-och-tar-sitt-forsta-steg-in-pa-den-amerikanska-marknaden/</loc>
		<lastmod>2025-02-27T20:23:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-erhaller-forsta-kommersiella-ordern-och-sakrar-beta-testning-av-acouwash-prototyp/</loc>
		<lastmod>2025-02-27T20:23:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-delarsrapport-2017-04-01-till-2017-06-30/</loc>
		<lastmod>2025-02-27T20:23:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-har-erhallit-notice-of-allowance-avseende-ansokan-om-patent-i-japan/</loc>
		<lastmod>2025-02-27T20:23:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/nulagesrapport-fran-acousort-ab-publ-efter-6-manader-som-noterat-bolag/</loc>
		<lastmod>2025-02-27T20:23:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kommunike-fran-arsstamma-i-acousort-ab-publ-8/</loc>
		<lastmod>2025-02-27T20:23:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/arsredovisning-2016/</loc>
		<lastmod>2025-02-27T20:23:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kallelse-till-arsstamma-i-acousort-ab-publ-8/</loc>
		<lastmod>2025-02-27T20:23:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/delarsrapport-2017-01-01-till-2017-03-31/</loc>
		<lastmod>2025-02-27T20:23:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/flaggningsmeddelande/</loc>
		<lastmod>2025-02-27T20:23:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ip-manager-receives-ingvar-carlsson-award/</loc>
		<lastmod>2025-02-27T20:23:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-valjer-att-inte-fullfolja-en-av-bolagets-patentansokningar/</loc>
		<lastmod>2025-02-27T20:23:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-tecknar-sitt-tredje-samarbetsavtal-om-oem-projekt/</loc>
		<lastmod>2025-02-27T20:23:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/bokslutskommunike-2016/</loc>
		<lastmod>2025-02-27T20:23:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-anstaller-marknads-och-forsaljningschef/</loc>
		<lastmod>2025-02-27T20:23:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-har-erhallit-notice-of-allowance-avseende-ansokan-om-patent-i-usa-och-ger-uppdatering-kring-europapatentet/</loc>
		<lastmod>2025-02-27T20:23:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/statusuppdatering-avseende-pagaende-projekt-och-aktiviteter/</loc>
		<lastmod>2025-02-27T20:23:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/forsta-dag-for-handel-pa-aktietorget/</loc>
		<lastmod>2025-02-27T20:23:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/marknadsmeddelande-3-17-acousort-ab-noteras-pa-aktietorget-den-9-januari-2017/</loc>
		<lastmod>2025-02-27T20:23:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/nyemission-infor-notering-pa-aktietorget-overtecknad/</loc>
		<lastmod>2025-02-27T20:23:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/fortydligande-om-tidigare-genomford-kvotvardesemission/</loc>
		<lastmod>2025-02-27T20:23:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/delarsrapport-2016-01-01-till-2016-09-30/</loc>
		<lastmod>2025-02-27T20:23:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/idag-inleds-teckningstiden-i-acousort-abs-nyemission/</loc>
		<lastmod>2025-02-27T20:23:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/offentliggorande-av-memorandum/</loc>
		<lastmod>2025-02-27T20:23:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-och-bio-recell-inleder-samarbete/</loc>
		<lastmod>2025-03-03T11:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-and-bio-recell-enter-collaboration/</loc>
		<lastmod>2025-03-03T11:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/the-board-of-directors-of-acousort-resolves-on-a-partially-secured-rights-issue-of-approximately-msek-34-1/</loc>
		<lastmod>2025-03-06T07:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/styrelsen-i-acousort-beslutar-om-en-partiellt-garanterad-foretradesemission-om-cirka-341-msek/</loc>
		<lastmod>2025-03-06T07:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/notice-of-extraordinary-general-meeting-in-acousort-ab-publ/</loc>
		<lastmod>2025-03-06T07:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kallelse-till-extra-bolagsstamma-i-acousort-ab-publ-2/</loc>
		<lastmod>2025-03-06T07:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/idag-inleds-utnyttjandeperioden-for-teckningsoptioner-av-serie-to-2-i-acousort/</loc>
		<lastmod>2025-03-10T07:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/the-exercise-period-for-warrants-of-series-to-2-in-acousort-begins-today/</loc>
		<lastmod>2025-03-10T07:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-to-explore-south-korean-opportunities-at-the-kimes-exhibition/</loc>
		<lastmod>2025-03-12T11:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-utforskar-mojligheterna-i-sydkorea-pa-kimes-massan/</loc>
		<lastmod>2025-03-12T11:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-i-nytt-samarbete-for-att-forbattra-behandling-av-sepsis/</loc>
		<lastmod>2025-03-19T08:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-in-new-collaboration-to-improve-sepsis-treatment/</loc>
		<lastmod>2025-03-19T08:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-offentliggor-utfall-av-utnyttjande-av-teckningsoptioner-av-serie-to-2/</loc>
		<lastmod>2025-03-25T06:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-announces-the-outcome-of-the-exercise-of-warrants-of-series-to-2/</loc>
		<lastmod>2025-03-25T06:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-vd-svarar-pa-fragor-om-bolagets-foretradesemission-och-ger-sin-syn-pa-framtiden/</loc>
		<lastmod>2025-03-26T08:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-ceo-answers-questions-about-the-companys-rights-issue-and-gives-his-view-on-the-future/</loc>
		<lastmod>2025-03-26T08:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/leading-global-pharma-company-prolongs-acouwash-lease-for-another-six-months/</loc>
		<lastmod>2025-04-01T06:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/ledande-globalt-lakemedelsbolag-forlanger-leasingavtal-for-acouwash-med-ytterligare-sex-manader/</loc>
		<lastmod>2025-04-01T06:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/bulletin-from-the-extraordinary-general-meeting-of-acousort-ab-publ/</loc>
		<lastmod>2025-04-09T07:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kommunike-fran-extra-bolagsstamma-i-acousort-ab-publ-2/</loc>
		<lastmod>2025-04-09T07:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-offentliggor-informationsdokument-i-samband-med-foretradesemission-av-aktier/</loc>
		<lastmod>2025-04-14T08:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-publishes-disclosure-document-in-connection-with-rights-issue-of-shares/</loc>
		<lastmod>2025-04-14T08:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/the-subscription-period-in-acousorts-rights-issue-of-shares-begins-today/</loc>
		<lastmod>2025-04-15T06:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/teckningsperioden-i-acousorts-foretradesemission-av-aktier-inleds-idag/</loc>
		<lastmod>2025-04-15T06:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/invitation-to-a-digital-company-presentation-about-acousort/</loc>
		<lastmod>2025-04-22T06:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/inbjudan-till-digital-bolagspresentation-om-acousort/</loc>
		<lastmod>2025-04-22T06:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/last-day-of-trading-in-subscription-rights-in-acousort/</loc>
		<lastmod>2025-04-29T06:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/sista-dag-for-handel-med-teckningsratter-i-acousort/</loc>
		<lastmod>2025-04-29T06:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-announces-preliminary-outcome-of-rights-issue-2/</loc>
		<lastmod>2025-05-05T18:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-offentliggor-preliminart-utfall-i-foretradesemission-2/</loc>
		<lastmod>2025-05-05T18:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-offentliggor-slutligt-utfall-i-foretradesemissionen/</loc>
		<lastmod>2025-05-06T18:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-announces-final-outcome-in-the-rights-issue/</loc>
		<lastmod>2025-05-06T18:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-foretradesemission-har-registrerats-omvandling-av-bta-till-aktier/</loc>
		<lastmod>2025-05-14T12:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-rights-issue-is-registered-conversion-of-bta-into-shares/</loc>
		<lastmod>2025-05-14T12:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-utvidgar-centraleuropeiskt-samarbete-via-ny-order/</loc>
		<lastmod>2025-05-21T10:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-strengthens-central-european-collaboration-with-new-order/</loc>
		<lastmod>2025-05-21T10:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kallelse-till-arsstamma-i-acousort-ab-publ-9/</loc>
		<lastmod>2025-05-23T06:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-arsredovisning-2024/</loc>
		<lastmod>2025-05-28T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-annual-report-2024/</loc>
		<lastmod>2025-05-28T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-interim-report-for-the-period-january-march-2025/</loc>
		<lastmod>2025-05-28T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-delarsrapport-for-perioden-1-januari-31-mars-2025/</loc>
		<lastmod>2025-05-28T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-selected-for-panel-participation-at-bio-2025/</loc>
		<lastmod>2025-06-13T11:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-inbjuden-till-paneldiskussion-pa-bio-2025/</loc>
		<lastmod>2025-06-13T11:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/huvudagarnas-forslag-infor-arsstamman-2025-i-acousort-ab-publ/</loc>
		<lastmod>2025-06-18T06:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/the-major-shareholders-proposal-for-the-2025-annual-general-meeting-of-acousort-ab/</loc>
		<lastmod>2025-06-18T11:04:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kommunike-fran-arsstamma-i-acousort-ab-publ-9/</loc>
		<lastmod>2025-06-25T10:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/communique-from-the-annual-general-meeting-of-acousort-ab-publ-2/</loc>
		<lastmod>2025-06-25T10:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-acouwash-technology-enables-centrifuge-free-cell-radiolabeling-using-acoustophoresis/</loc>
		<lastmod>2025-07-28T06:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-acouwash-teknologi-mojliggor-centrifugfri-radiomarkning-av-celler-med-hjalp-av-akustofores/</loc>
		<lastmod>2025-07-28T06:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-halvarsrapport-for-perioden-1-januari-30-juni-2025/</loc>
		<lastmod>2025-08-27T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-interim-report-for-the-period-january-june-2025/</loc>
		<lastmod>2025-08-27T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-changes-certified-adviser-to-tapper-partners-ab/</loc>
		<lastmod>2025-09-03T07:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-byter-certified-adviser-till-tapper-partners-ab/</loc>
		<lastmod>2025-09-03T07:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-invited-to-present-at-10th-bioproduction-congress-in-lyon/</loc>
		<lastmod>2025-09-15T13:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-inbjudet-att-presentera-vid-den-10e-bioproduction-congress-i-lyon/</loc>
		<lastmod>2025-09-15T13:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-presenterar-pa-redeyes-temaevent-tools-and-supplies-in-life-science-2025/</loc>
		<lastmod>2025-09-17T11:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-to-present-at-redeyes-theme-event-tools-and-supplies-in-life-science-2025/</loc>
		<lastmod>2025-09-17T11:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-receives-new-order-boosting-central-european-collaboration/</loc>
		<lastmod>2025-09-22T08:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-far-ny-order-som-starker-centraleuropeiskt-samarbete/</loc>
		<lastmod>2025-09-22T08:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-och-danska-seeq-diagnostics-tecknar-avtal-om-teknikutvardering/</loc>
		<lastmod>2025-11-19T09:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-and-danish-seeq-diagnostics-sign-technology-evaluation-agreement/</loc>
		<lastmod>2025-11-19T09:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-delarsrapport-for-perioden-1-januari-30-september-2025/</loc>
		<lastmod>2025-11-26T05:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-interim-report-for-the-period-january-september-2025/</loc>
		<lastmod>2025-11-26T05:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/stefan-blomsterberg-valdes-till-ny-styrelseordforande-i-acousort/</loc>
		<lastmod>2025-12-15T07:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/stefan-blomsterberg-elected-new-chairman-of-the-board-of-acousort/</loc>
		<lastmod>2025-12-15T07:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-och-mfx-ingar-samarbete-for-att-effektivisera-framtida-tillverkning-av-cellterapi/</loc>
		<lastmod>2025-12-19T09:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-and-mfx-enter-a-collaboration-to-streamline-future-cell-therapy-manufacturing/</loc>
		<lastmod>2025-12-19T09:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-tecknar-ytterligare-tre-kontrakt-for-acouwash-system/</loc>
		<lastmod>2025-12-29T09:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-signs-three-more-acouwash-system-contracts/</loc>
		<lastmod>2025-12-29T09:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-inleder-nytt-samarbete-med-global-tillverkare/</loc>
		<lastmod>2026-01-23T10:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-initiates-new-collaboration-with-global-manufacturer/</loc>
		<lastmod>2026-01-23T10:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/year-end-report-for-acousort-ab-1-january-31-december-2025/</loc>
		<lastmod>2026-02-25T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/bokslutskommunike-for-acousort-ab-1-januari-31-december-2025/</loc>
		<lastmod>2026-02-25T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-far-forskottsbetalning-av-royalties/</loc>
		<lastmod>2026-03-10T16:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-receives-prepayment-of-royalties/</loc>
		<lastmod>2026-03-10T16:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-technology-exhibited-together-with-moeller-medicals-system-at-analytica/</loc>
		<lastmod>2026-03-16T07:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousorts-teknologi-stalls-ut-tillsammans-med-moeller-medicals-system-pa-analytica/</loc>
		<lastmod>2026-03-16T07:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-saljer-ett-acoutrap-system-till-hebrew-university-of-jerusalem/</loc>
		<lastmod>2026-04-16T09:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-sell-an-acoutrap-system-to-the-hebrew-university-of-jerusalem/</loc>
		<lastmod>2026-04-16T09:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kallelse-till-arsstamma-i-acousort-ab-publ-10/</loc>
		<lastmod>2026-05-18T06:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-annual-report-2025/</loc>
		<lastmod>2026-05-20T12:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-arsredovisning-2025/</loc>
		<lastmod>2026-05-20T12:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-interim-report-for-the-period-january-march-2026/</loc>
		<lastmod>2026-05-27T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-delarsrapport-for-perioden-1-januari-31-mars-2026/</loc>
		<lastmod>2026-05-27T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-to-present-and-exhibit-at-the-cyto-conference-in-west-palm-beach-in-june/</loc>
		<lastmod>2026-06-01T09:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-presenterar-och-staller-ut-pa-cyto-konferensen-i-west-palm-beach-i-juni/</loc>
		<lastmod>2026-06-01T09:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-receives-an-order-for-acouwash-from-a-global-leader-in-veterinary-diagnostics/</loc>
		<lastmod>2026-06-03T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-far-order-pa-acouwash-fran-global-ledare-inom-veterinardiagnostik/</loc>
		<lastmod>2026-06-03T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kommunike-fran-arsstamma-i-acousort-ab/</loc>
		<lastmod>2026-06-18T07:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-invited-to-key-marketing-and-partnering-events-in-japan/</loc>
		<lastmod>2026-06-29T07:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-deltar-i-viktiga-marknadsforings-och-partnering-evenemang-i-japan/</loc>
		<lastmod>2026-06-29T07:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-halvarsrapport-for-perioden-1-januari-30-juni-2026/</loc>
		<lastmod>2026-08-26T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-interim-report-for-the-period-january-june-2026/</loc>
		<lastmod>2026-08-26T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-enters-into-strategic-oem-supply-agreement-with-calyrex-biosystems-inc-and-marketing-agreement-with-intelmetis-inc-combined-with-a-sek-15m-convertible-note-financing/</loc>
		<lastmod>2026-10-01T20:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/acousort-ab-ingar-strategiskt-oem-leveransavtal-med-calyrex-biosystems-inc-och-marknadsforingsavtal-med-intelmetis-inc-i-kombination-med-en-konvertibelemission-om-15-msek/</loc>
		<lastmod>2026-10-01T20:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/kallelse-till-extra-bolagsstamma-i-acousort-ab-publ-3/</loc>
		<lastmod>2026-10-02T13:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://acousort.com/mfn_news/notice-of-extraordinary-general-meeting-in-acousort-ab-publ-2/</loc>
		<lastmod>2026-10-02T13:23:00+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->